BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Feng R, Cheng DX, Chen XC, Yang L, Wu H. Application of sintilimab combined with anlotinib hydrochloride in the clinical treatment of microsatellite stable colorectal cancer. World J Gastrointest Oncol 2023; 15(11): 1925-1935 [PMID: 38077647 DOI: 10.4251/wjgo.v15.i11.1925]
URL: https://www.wjgnet.com/1948-5204/full/v15/i11/1925.htm
Number Citing Articles
1
Mateusz Kciuk, Katarzyna Wanke, Weronika Kruczkowska, Beata Marciniak, Renata Kontek. Focus on PD-1/PD-L1-Targeting Antibodies in Colorectal Cancer: Are There Options Beyond Dostarlimab, Nivolumab, and Pembrolizumab? A Comprehensive ReviewMolecules 2025; 30(13): 2686 doi: 10.3390/molecules30132686